Skip to main content
logo
Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
12.57
-0.03 (-0.24%)
At close: Jan 22, 2026, 4:00 PM EST
12.58
+0.01 (0.08%)
After-hours: Jan 22, 2026, 5:04 PM EST

Arvinas Revenue

Arvinas had revenue of $41.90M in the quarter ending September 30, 2025, a decrease of -59.08%. This brings the company's revenue in the last twelve months to $312.30M, up 93.85% year-over-year. In the year 2024, Arvinas had annual revenue of $263.40M with 235.54% growth.

Revenue (ttm)
$312.30M
Revenue Growth
+93.85%
P/S Ratio
2.93
Revenue / Employee
$726,279
Employees
430
Market Cap
807.30M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024263.40M184.90M235.54%
Dec 31, 202378.50M-52.90M-40.26%
Dec 31, 2022131.40M77.80M145.15%
Dec 31, 202153.60M27.70M106.95%
Dec 31, 202025.90M-17.10M-39.77%
Dec 31, 201943.00M28.68M200.20%
Dec 31, 201814.32M6.75M89.00%
Dec 31, 20177.58M909.85K13.64%
Dec 31, 20166.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MiMedx Group393.44M
Geron183.40M
REGENXBIO161.32M
Kura Oncology104.03M
Arbutus Biopharma14.61M
Janux Therapeutics10.00M
KalVista Pharmaceuticals1.43M
YD Bio510.36K
Revenue Rankings

ARVN News

More News